U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219550) titled 'A Study of MK-1084 in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)' on Oct. 20.
Brief Summary: The purpose of this study is to learn what happens to MK-1084 levels in a person's body over time. Researchers will measure what happens to MK-1084 levels in the body when it is given to participants with hepatic (liver) impairment and healthy participants. Researchers also want to learn about the safety of MK-1084 when it is given to people with hepatic impairment and if people with hepatic impairment can tolerate it.
Study Start Date: Nov. 03
Study Type: INTERVENTIONAL
Condition:
Healthy
Hepatic Impairmen...